France
· Delayed Price · Currency is EUR Global Bioenergies Statistics
Total Valuation
EPA:ALGBE has a market cap or net worth of EUR 22.48 million. The enterprise value is 23.27 million.
| Market Cap | 22.48M |
| Enterprise Value | 23.27M |
Important Dates
The next estimated earnings date is Tuesday, June 10, 2025.
| Earnings Date | Jun 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EPA:ALGBE has 18.13 million shares outstanding. The number of shares has increased by 1.56% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | +1.56% |
| Shares Change (QoQ) | -3.00% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 3.65% |
| Float | 15.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 62.97 |
| PB Ratio | 13.28 |
| P/TBV Ratio | 13.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.97 |
| EV / Sales | 64.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.92 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 3.34.
| Current Ratio | 1.43 |
| Quick Ratio | 1.11 |
| Debt / Equity | 3.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.71 |
| Interest Coverage | -22.55 |
Financial Efficiency
Return on equity (ROE) is -96.88% and return on invested capital (ROIC) is -37.34%.
| Return on Equity (ROE) | -96.88% |
| Return on Assets (ROA) | -30.21% |
| Return on Invested Capital (ROIC) | -37.34% |
| Return on Capital Employed (ROCE) | -189.80% |
| Revenue Per Employee | 8,388 |
| Profits Per Employee | -136,302 |
| Employee Count | 43 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.00% in the last 52 weeks. The beta is 1.67, so EPA:ALGBE's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | -35.00% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 43.29 |
| Average Volume (20 Days) | 25,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:ALGBE had revenue of EUR 360,664 and -5.86 million in losses. Loss per share was -0.32.
| Revenue | 360,664 |
| Gross Profit | -488,517 |
| Operating Income | -6.74M |
| Pretax Income | -7.11M |
| Net Income | -5.86M |
| EBITDA | -4.24M |
| EBIT | -6.74M |
| Loss Per Share | -0.32 |
Balance Sheet
The company has 4.86 million in cash and 5.65 million in debt, giving a net cash position of -791,272 or -0.04 per share.
| Cash & Cash Equivalents | 4.86M |
| Total Debt | 5.65M |
| Net Cash | -791,272 |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 1.69M |
| Book Value Per Share | 0.09 |
| Working Capital | 2.65M |
Cash Flow
In the last 12 months, operating cash flow was -7.51 million and capital expenditures -466,367, giving a free cash flow of -7.97 million.
| Operating Cash Flow | -7.51M |
| Capital Expenditures | -466,367 |
| Free Cash Flow | -7.97M |
| FCF Per Share | -0.44 |
Margins
| Gross Margin | -135.45% |
| Operating Margin | -1,869.85% |
| Pretax Margin | -1,971.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EPA:ALGBE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.56% |
| Shareholder Yield | -1.56% |
| Earnings Yield | -26.07% |
| FCF Yield | -35.46% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:ALGBE has an Altman Z-Score of -0.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.6 |
| Piotroski F-Score | n/a |